Amarin Corp Plc (AMRN)

[roadkilll]

Pfizer would have seen this Supreme Court ruling and contacted Generics in writing with a threat of treble damages.
Supreme Court Denies Cert. in Skinny Label Case, but the Impacts from GSK v. Teva Continue
May 15, 2023
Chad Landmon, Matthew S. Murphy, Ross E. Blau and Gulrukh Haroon*
Today, the Supreme Court denied certiorari in Teva Pharms. USA, Inc. v. GlaxoSmithKline, LLC, 22-37, locking in the Federal Circuit’s second panel decision (hereafter “GSK v. Teva”), which held that Teva’s attempted section viii carveout of an indication covered by a patented method of use was not “skinny” enough to avoid being liable for infringement.

* (producing 10X demand for >500 mg trigs with (intent) to infringe)
Doctors records would quickly show how many Rx's were written for patients with trigs under 500. Yes, dat could be collected without crossing HIPPA act.